Teva Pharmaceutical (Germany) Buy Hold or Sell Recommendation
| TEV Stock | EUR 14.00 0.50 3.45% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Teva Pharmaceutical Industries is 'Strong Sell'. Macroaxis provides Teva Pharmaceutical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TEV positions.
Check out Teva Pharmaceutical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Teva and provide practical buy, sell, or hold advice based on investors' constraints. Teva Pharmaceutical Industries. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Teva |
Execute Teva Pharmaceutical Buy or Sell Advice
The Teva recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Teva Pharmaceutical Industries. Macroaxis does not own or have any residual interests in Teva Pharmaceutical Industries or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Teva Pharmaceutical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Teva Pharmaceutical Trading Alerts and Improvement Suggestions
| Teva Pharmaceutical generated a negative expected return over the last 90 days | |
| Teva Pharmaceutical has high historical volatility and very poor performance | |
| Teva Pharmaceutical has high likelihood to experience some financial distress in the next 2 years | |
| Teva Pharmaceutical has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| Teva Pharmaceutical Industries has accumulated 19.1 B in total debt with debt to equity ratio (D/E) of 184.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Teva Pharmaceutical has a current ratio of 0.94, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Teva Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Teva Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Teva Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Teva to invest in growth at high rates of return. When we think about Teva Pharmaceutical's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 14.93 B. Net Loss for the year was (2.35 B) with profit before overhead, payroll, taxes, and interest of 6.97 B. |
Teva Pharmaceutical Returns Distribution Density
The distribution of Teva Pharmaceutical's historical returns is an attempt to chart the uncertainty of Teva Pharmaceutical's future price movements. The chart of the probability distribution of Teva Pharmaceutical daily returns describes the distribution of returns around its average expected value. We use Teva Pharmaceutical Industries price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Teva Pharmaceutical returns is essential to provide solid investment advice for Teva Pharmaceutical.
| Mean Return | -0.07 | Value At Risk | -4.42 | Potential Upside | 3.50 | Standard Deviation | 4.19 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Teva Pharmaceutical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Teva Pharmaceutical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Teva Pharmaceutical or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Teva Pharmaceutical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Teva stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.19 | |
β | Beta against Dow Jones | -1.44 | |
σ | Overall volatility | 4.38 | |
Ir | Information ratio | -0.0006 |
Teva Pharmaceutical Volatility Alert
Teva Pharmaceutical Industries exhibits very low volatility with skewness of 2.85 and kurtosis of 20.43. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Teva Pharmaceutical's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Teva Pharmaceutical's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Teva Pharmaceutical Fundamentals Vs Peers
Comparing Teva Pharmaceutical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Teva Pharmaceutical's direct or indirect competition across all of the common fundamentals between Teva Pharmaceutical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Teva Pharmaceutical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Teva Pharmaceutical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Teva Pharmaceutical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Teva Pharmaceutical to competition |
| Fundamentals | Teva Pharmaceutical | Peer Average |
| Return On Equity | -0.24 | -0.31 |
| Return On Asset | 0.0363 | -0.14 |
| Profit Margin | (0.16) % | (1.27) % |
| Operating Margin | 0.18 % | (5.51) % |
| Current Valuation | 28.17 B | 16.62 B |
| Shares Outstanding | 1.11 B | 571.82 M |
| Shares Owned By Insiders | 2.00 % | 10.09 % |
| Shares Owned By Institutions | 49.70 % | 39.21 % |
| Price To Book | 1.16 X | 9.51 X |
| Price To Sales | 0.61 X | 11.42 X |
| Revenue | 14.93 B | 9.43 B |
| Gross Profit | 6.97 B | 27.38 B |
| EBITDA | (827 M) | 3.9 B |
| Net Income | (2.35 B) | 570.98 M |
| Cash And Equivalents | 1.97 B | 2.7 B |
| Cash Per Share | 1.81 X | 5.01 X |
| Total Debt | 19.1 B | 5.32 B |
| Debt To Equity | 184.30 % | 48.70 % |
| Current Ratio | 0.96 X | 2.16 X |
| Book Value Per Share | 7.11 X | 1.93 K |
| Cash Flow From Operations | 1.59 B | 971.22 M |
| Earnings Per Share | (1.96) X | 3.12 X |
| Price To Earnings To Growth | 0.75 X | 4.89 X |
| Target Price | 11.47 | |
| Number Of Employees | 34 K | 18.84 K |
| Beta | 1.22 | -0.15 |
| Market Capitalization | 10.47 B | 19.03 B |
| Total Asset | 44.01 B | 29.47 B |
| Five Year Return | 3.24 % | |
| Net Asset | 44.01 B |
Teva Pharmaceutical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Teva . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Teva Pharmaceutical Buy or Sell Advice
When is the right time to buy or sell Teva Pharmaceutical Industries? Buying financial instruments such as Teva Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Teva Pharmaceutical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Furniture Thematic Idea Now
Furniture
Companies producing and selling home and office furniture. The Furniture theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Furniture Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Teva Stock
Teva Pharmaceutical financial ratios help investors to determine whether Teva Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Teva with respect to the benefits of owning Teva Pharmaceutical security.